Atturos - Dublin

Founded in 2014, Atturos is a spin-off company from University College Dublin that is dedicated to developing and commercializing advanced diagnostics solutions. Their aim is to enable both clinicians and patients to make more informed decisions. Utilizing their vast knowledge in mass spectrometry, proteomics, and clinical research, Atturos is focused on the clinical and commercial translation of their leading product, the OCProDx test. This innovative multi-marker test is being developed to meet a major need in the field of prostate cancer treatment. Thanks to the support of the EU Horizon 2020 SME Instrument award, the Atturos leadership team is working closely with various partners in the clinical, scientific, and business sectors to promote the fast growth and development of the  

Show more

company.

The Atturos team is determined to achieve success with their plans, but they also understand that the outcomes of the tests they develop may have a major impact on the lives of patients. It is for this reason that they strive to prioritize integrity in all their activities in close collaboration with both patients and clinicians.